Scientific article

Cellular and molecular effects of the mTOR inhibitor everolimus

Published inClinical science, vol. 129, no. 10, p. 895-914
Publication date2015

mTOR (mechanistic target of rapamycin) functions as the central regulator for cell proliferation, growth and survival. Up-regulation of proteins regulating mTOR, as well as its downstream targets, has been reported in various cancers. This has promoted the development of anti-cancer therapies targeting mTOR, namely fungal macrolide rapamycin, a naturally occurring mTOR inhibitor, and its analogues (rapalogues). One such rapalogue, everolimus, has been approved in the clinical treatment of renal and breast cancers. Although results have demonstrated that these mTOR inhibitors are effective in attenuating cell growth of cancer cells under in vitro and in vivo conditions, subsequent sporadic response to rapalogues therapy in clinical trials has promoted researchers to look further into the complex understanding of the dynamics of mTOR regulation in the tumour environment. Limitations of these rapalogues include the sensitivity of tumour subsets to mTOR inhibition. Additionally, it is well known that rapamycin and its rapalogues mediate their effects by inhibiting mTORC (mTOR complex) 1, with limited or no effect on mTORC2 activity. The present review summarizes the pre-clinical, clinical and recent discoveries, with emphasis on the cellular and molecular effects of everolimus in cancer therapy.

  • Antineoplastic Agents/pharmacology
  • Autophagy/drug effects
  • Cell Proliferation/drug effects
  • Everolimus
  • Humans
  • Immunosuppressive Agents/pharmacology
  • Models, Biological
  • Multiprotein Complexes/antagonists & inhibitors/metabolism
  • Signal Transduction/drug effects
  • Sirolimus/analogs & derivatives/pharmacology
  • TOR Serine-Threonine Kinases/antagonists & inhibitors/metabolism
Citation (ISO format)
SARAN, Uttara, FOTI, Michelangelo, DUFOUR, Jean-François. Cellular and molecular effects of the mTOR inhibitor everolimus. In: Clinical science, 2015, vol. 129, n° 10, p. 895–914. doi: 10.1042/CS20150149
Main files (1)
Article (Published version)
ISSN of the journal0143-5221

Technical informations

Creation11/10/2016 10:26:00 AM
First validation11/10/2016 10:26:00 AM
Update time03/15/2023 12:54:47 AM
Status update03/15/2023 12:54:46 AM
Last indexation10/19/2023 2:22:21 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack